MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20244195

June 28, 2024

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

10ml:5mg

化学药品

June 28, 2024

Company Information

Applicant Company

重庆市北碚区水土镇方正大道21号

Manufacturing Company

重庆市北碚区水土镇方正大道21号附2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath